So easy to rebut your rebuttal...
So easy to rebuttal....
First time leading a company...and yet, he single-handedly saved it from BK and is now debt-free with $150 Million in the bank That makes a great CFO....not CEO That doesn't change the fact that he single-handedly rescued the company from BK. Furthermore, he is responsible for building the company from 1 employee to 40 employees...creating the management structure...and attracting some of the best Biotech executives in the industry. THAT makes a good CEO.
First time doing trials...and yet, every trial has been a success. Success??? Then where is the TLD on all those successful trials??? You're taking things out of context. Most of those trials were P1s and P2s. The only P3s were the adult Rett AVATAR trial and the P2b/3 AD trial. The adult Avatar P3 is the first half of the NDA and the pediatric Excellence P2/3 is the second half. (Can't put the horse before the cart) The NDA for the P2b/3 AD trial will be submitted after the Rett trial is submitted.
First time trying to commercialize...and yet, we are 6-12 months away from commercializing A2-73 for Rett. How do you know that? We haven't seen the TLD yet??? If the Excellence trial had failed, that would be a material event and we would know that by now.
First time dealing with regulators...and yet, he was smart enough to hire the top-dog from the FDA to ensure our approval process. You got to be kidding...How many years has it been since he hired his first ex-FDA'er? Everyone was touting back then that would expedite trials...LOL...nothing was expedited...Lets hope his 3RD ex-FDA-er works out. Once again you are taking things out of context. Those other "ex-FDA'ers" were hired during the P1 and P2 trials. We just finished the AVATAR trial last year...and that is the first half of the NDA for Rett. TGD hired Dr. Kun Jin in January just after the P2b/3 AD trial ended. Everything is in place for success.
First time dealing directly with shareholders...as it turns out, the largest shareholders of AVXL are institutions. Yet the share price is controlled by the fudster bas with his daily hype (except when he is selling and reloading). If tutes were committed (besides Index funds) then we wouldn't be at $5. More likely $25. The entire market has been selling off. Until we submit an NDA we will continue to follow the XBI - which is at a 52-week low right now.
Quite an accomplishment, no? Funny things happen when one is so heavy invested that they fail to see reality. I see reality just fine. There's probably 100 biotech companies that would love to have $150 Million in the bank and debt-free. We are in great shape for the future. Not too many biotech companies can say that.
Market Data 
Markets 
AI
